Home Ingredients ThinOgen® (Fucoxanthin from Brown Seaweed — BGG)
Weight ManagementMetabolic Health

ThinOgen® (Fucoxanthin from Brown Seaweed — BGG)

Undaria pinnatifida
Evidence Level
Limited
2 Clinical Trials
5 Documented Benefits
2/5 Evidence Score

ThinOgen® is a fucoxanthin extract from brown seaweed (Undaria pinnatifida) sold by BGG. Fucoxanthin is a marine carotenoid that raises UCP1 and thermogenesis in animal studies. The main human weight-loss evidence comes from one trial of a fucoxanthin plus pomegranate-seed-oil combination, not from ThinOgen itself, and a fucoxanthin-alone trial found no extra weight loss. Used for: weight management, metabolic health.

Studied Dose 2.4 mg/day fucoxanthin, the amount used in the 16-week Xanthigen trial where it was combined with pomegranate seed oil. ThinOgen itself has not been tested at any dose in a published trial.
Active Compound Fucoxanthin from Undaria pinnatifida (wakame brown seaweed)

Benefits

Body Fat Reduction

RCT (n=151) of fucoxanthin + pomegranate seed oil showed body weight, BMI, body fat reductions vs placebo over 16 weeks. Foundation fucoxanthin weight management evidence.

Supported by Trial 1

UCP1 Thermogenic Pathway Activation

Fucoxanthin uniquely activates UCP1 (uncoupling protein 1) in white adipose tissue — promotes 'browning' of white fat to thermogenic brown-like fat; mechanism distinct from most weight ingredients.

Supported by Trial 1

Metabolic Health Support

Blood lipid improvements (triglycerides, lipid profile) were reported in the human trials, though partly from the pomegranate-seed-oil combination or alongside a diet and exercise program. Effects on insulin sensitivity and blood pressure are not established in people.

Supported by Trial 1, Trial 2

Liver Triglyceride Reduction

Some evidence for fucoxanthin reducing liver fat accumulation; relevant to fatty liver concerns.

Supported by Trial 1, Trial 2

Marine Carotenoid Distinction

Fucoxanthin is one of few orange-colored carotenoids found in marine sources rather than terrestrial; unique structure and activity.

Supported by Trial 1, Trial 2

Mechanism of action

1

UCP1 Upregulation in White Adipose

Fucoxanthin uniquely upregulates UCP1 — protein that uncouples mitochondrial respiration from ATP production, dissipating energy as heat (thermogenesis). Most relevant in brown adipose tissue normally; fucoxanthin promotes 'browning' of white fat.

2

Beta-3 Adrenergic Receptor Activation

Activates beta-3 adrenergic receptors — promotes lipolysis and thermogenesis.

3

PPAR-Gamma Modulation

Modulates PPAR-gamma — adipocyte differentiation transcription factor.

4

Wakame Brown Seaweed Source

Undaria pinnatifida is edible brown seaweed used culinarily in Japanese cuisine; high natural fucoxanthin content.

Clinical trials

1
Xanthigen (Fucoxanthin plus Pomegranate Seed Oil) for Weight Management
PubMed

16-week double-blind RCT of Xanthigen (300 mg pomegranate seed oil plus 300 mg brown seaweed extract containing 2.4 mg fucoxanthin) in 151 obese non-diabetic premenopausal women.

151 obese non-diabetic premenopausal women.

Body weight fell about 5 kg versus placebo over 16 weeks, with reductions in body fat, liver fat, triglycerides and CRP. Because the product combined fucoxanthin with pomegranate seed oil, the result cannot be assigned to fucoxanthin alone.

2
No Published ThinOgen-Specific Trial

A PubMed search for ThinOgen returns no results, and no trial of the ThinOgen brand has been published in the indexed literature.

Not applicable: no published ThinOgen study exists.

None available. Any claims about ThinOgen rely on trials of other fucoxanthin products, not on ThinOgen itself.

Side effects and drug interactions

Common Potential side effects

Generally well-tolerated.
Mild GI distress.
Iodine content from seaweed source — relevant for thyroid considerations.
Allergic reactions to seaweed rare.
Effects build over 8-16 weeks; not immediate.

Important Drug interactions

Thyroid medications: brown seaweed carries an iodine load, and both iodine excess and deficiency can disturb thyroid function, so anyone on thyroid medication or with thyroid disease should be cautious and confirm the product's iodine content with their doctor.
Anticoagulants — modest interactions.
Diabetes medications — modest hypoglycemic effects.
Pregnancy — limited safety data; avoid.
Lactation — limited data.
Hyperthyroidism — caution with seaweed-derived ingredients.

More Weight Management Ingredients

Weight Management
Glucomannan (Konjac Root Fiber)
Glucomannan is a water-soluble dietary fiber derived from the root of the konjac plant (Am…
Weight Management
Metabolaid® (Hibiscus + Lemon Verbena)
Metabolaid® (Monteloeder/SuanNutra) is a patented combination of Hibiscus sabdariffa and L…
Weight Management
Trpti™ (Bioavailable Oleoylethanolamide / OEA — Saanroo)
Trpti™ (Hindi for 'satisfaction') is Saanroo's branded bioavailable oleoylethanolamide (OE…
Weight Management
Capsifen® (Bioavailable Capsaicinoids via FenuMat® — Akay Bioactives)
Capsifen is Akay Bioactives' red chili (Capsicum annum) capsaicinoid complex delivered via…

Explore Other Ingredients

Antioxidant
Alpha Lipoic Acid
Alpha-lipoic acid (ALA) is a versatile antioxidant made naturally in the body that is unus…
Antioxidant
Milk Thistle
Milk thistle, from the Silybum marianum plant, contains silymarin, a group of plant compou…
Antioxidant
Dandelion Root
Dandelion root is a traditional herb used to support liver and digestive health and as a g…

Frequently asked questions about ThinOgen® (Fucoxanthin from Brown Seaweed — BGG)

What is ThinOgen?

ThinOgen® is a fucoxanthin extract from brown seaweed (Undaria pinnatifida) sold by BGG. Fucoxanthin is a marine carotenoid that raises UCP1 and thermogenesis in animal studies.

What is ThinOgen used for?

ThinOgen is researched primarily for Weight Management and Metabolic Health. RCT (n=151) of fucoxanthin + pomegranate seed oil showed body weight, BMI, body fat reductions vs placebo over 16 weeks. Foundation fucoxanthin weight management evidence.

What is the recommended dosage of ThinOgen?

The clinically studied dose is 2.4 mg/day fucoxanthin, the amount used in the 16-week Xanthigen trial where it was combined with pomegranate seed oil. ThinOgen itself has not been tested at any dose in a published trial. Always follow the product label and check with a healthcare provider for personal advice.

Is ThinOgen safe, and does it have side effects?

For most healthy adults, ThinOgen is well tolerated at studied doses. Reported effects can include: Generally well-tolerated. Mild GI distress. It may also interact with some medications. ThinOgen is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does ThinOgen interact with any medications?

Possible interactions include: Thyroid medications: brown seaweed carries an iodine load, and both iodine excess and deficiency can disturb thyroid function, so anyone on thyroid medication or with thyroid disease should be cautious and confirm the product's iodine content with their doctor. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for ThinOgen?

NutraSmarts rates the evidence for ThinOgen as Limited (2 out of 5). It is backed by 2 clinical trials and 3 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(3 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Abidov M, Ramazanov Z, Seifulla R, Grachev S The effects of Xanthigen in the weight management of obese premenopausal women with non-alcoholic fatty liver disease and normal liver fat Diabetes Obes Metab. 2010;12(1):72-81. doi: 10.1111/j.1463-1326.2009.01132.x.PubMedUsed to support: Body fat / liver fat / weight reduction from the Xanthigen combination
  2. Dickerson B, Maury J, Jenkins V, et al. Effects of Supplementation with Microalgae Extract from Phaeodactylum tricornutum (Mi136) to Support Benefits from a Weight Management Intervention in Overweight Women Nutrients. 2024;16(7):990. doi: 10.3390/nu16070990.PubMedUsed to support: Fucoxanthin-alone RCT null for weight/fat loss
  3. Li H, Qi J, Li L Phytochemicals as potential candidates to combat obesity via adipose non-shivering thermogenesis Pharmacol Res. 2019;147:104393. doi: 10.1016/j.phrs.2019.104393.PubMedUsed to support: Review covering fucoxanthin's UCP1-mediated thermogenic mechanism in adipose tissue; backs 'UCP1 thermogenic pathway activation' benefit as mechanistic basis. Predominantly animal/in vitro evidence reviewed; not a human clinical study.